Programs and studies

Clinical study

Phage Therapy for the Treatment of Urinary Tract Infection

StatusStatus unconfirmed
TypeIndividual-case protocol
CountriesCanada
Conditions studiedRecurrent Urinary Tract Infection
Study years2023–2024 (estimated)
Entry review2026-10-03

Participation

Check the study record or contact the study team for current recruitment and eligibility.

Study eligibility

Inclusion Criteria: * Diagnosis of recurrent chronic urinary tract infections with severe long term effects * Can speak and understand English * Willing to follow the protocol Exclusion Criteria: * Stage 5 chronic kidney disease * Abnormal liver function tests * A urinary stent or chronic indwelling catheterization * A known allergy to phage products * Fever * Pregnancy * Involved in another clinical trial

Study description

This is a single-patient, phase I/II clinical trial that aims to evaluate the potential of bacteriophage therapy to treat and prevent the recurrence of a drug-resistant urinary tract infection with serious long-term effects. This study will follow a minimally invasive phage therapy approach consisting of oral, topical (opening of the urethra) and bladder installations of a 3-phage cocktail comprised of HP3, HP3.1 and ES19.

Study registrations

ClinicalTrials.govNCT05537519
Recorded study locations (1)

Locations listed in the study record; this does not confirm current recruitment or treatment outside the study. A site label may be older than the overall study status.

St. Joseph's Health Centre

Toronto, Ontario, Canada

Recorded site status: Not separately listed. Study location source ↗

Related programs(1)

Notes from the source review
  • Single-patient Canadian UTI protocol (actual n=1), status unknown; not a broad enrollment route.
Sources and updates

Entry reviewed . This is the date of our source review, not a confirmation of availability today.

AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.

Study ID
nct05537519